deltatrials

Non-alcoholic steatohepatitis Trials in Boston, United States

Conditions / Non-alcoholic steatohepatitis / Boston, United States

Non-alcoholic steatohepatitis has been the subject of sustained clinical investigation across multiple research sites.

10 total trials for this combination

Trials

NCT ID Title Status Phase
NCT04657523 Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study COMPLETED NA
NCT06138821 Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial RECRUITING NA
NCT02686762 Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis COMPLETED PHASE2
NCT04822181 Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) ACTIVE_NOT_RECRUITING
NCT03987451 A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage COMPLETED PHASE2
NCT02787304 Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) TERMINATED PHASE2
NCT05463796 InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer RECRUITING
NCT00678587 Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures TERMINATED PHASE3
NCT00680407 Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis COMPLETED PHASE2
NCT05728697 Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease RECRUITING

Related Pages